| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |